HeartFlowHTFL -15.83%12 Net Margin % is -52.07% as of Mar. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, HeartFlow ranks worse than 86.47% on this metric.
Net margin is calculated as Net Income divided by its Revenue. HeartFlow's Net Income for the
three
months ended in Mar. 2026 was $-27.4 Mil. HeartFlow's Revenue for the
three
months ended in Mar. 2026 was $52.6 Mil. Therefore, HeartFlow's net margin for the quarter that ended in Mar. 2026 was -52.07%.
The historical rank and industry rank for HeartFlow's Net Margin % or its related term are showing as below:
HTFL'
s Net Margin % Range Over the Past 10 Years
Min: -109.73 Med: -76.65 Max: -58.42
Current: -58.42
HTFL's Net Margin % is ranked worse than 86.47% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.89
vs HTFL: -58.42
HeartFlow (NAS:HTFL) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
HeartFlow Net Margin % Related Terms
HeartFlow Net Margin % Historical Data
* Premium members only.
The historical data trend for HeartFlow's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, HeartFlow's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartFlow Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartFlow's Net Margin % distribution charts can be found below:
* The bar in red indicates where HeartFlow's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartFlow (HTFL) has a Net Margin % of -52.07% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on HeartFlow and its competitors. According to the industry distribution chart, HeartFlow ranks #575 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 86.5%.
Is HeartFlow's Net Margin % too high?
HeartFlow's current Net Margin % is -52.07%. Based on the distribution chart, HeartFlow ranks #575 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Net Margin % compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, HeartFlow ranks #575 out of 665 companies for Net Margin %. This places HeartFlow in the lower half of its industry. The industry median Net Margin % is 2.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on HeartFlow and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartFlow's current Net Margin % is -52.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Net Margin % of -52.07%. The current Net Margin % is -52.07%. HeartFlow's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For HeartFlow (HTFL), the current Net Margin % is -52.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score
Get the complete analysis for HTFL
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HTFL has been successfully added to your 
